低剂量司美格鲁肽对1型糖尿病超重患者的影响。
Effect of low dose Semaglutide in people with Type 1 Diabetes and excess weight.
作者信息
Grassi Bruno A, Teresa Onetto María, Sánchez Camila, Tapia Nicole, Mena Francisca
机构信息
Departamento de Nutrición, Diabetes y Metabolismo, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Diagonal Paraguay 362, Santiago, Chile.
Departamento de Nutrición, Diabetes y Metabolismo, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Diagonal Paraguay 362, Santiago, Chile.
出版信息
Diabetes Res Clin Pract. 2024 Mar;209:111593. doi: 10.1016/j.diabres.2024.111593. Epub 2024 Feb 24.
Obesity is a prevalent problem in people living with T1D (PwT1D), and it has been linked to cardiovascular disease in this population. The use of low dose weekly Semaglutide (0,5 mg) was evaluated in a cohort of PwT1D and excess weight.
肥胖是1型糖尿病患者（T1D患者）中普遍存在的问题，并且它与该人群的心血管疾病有关。在一组T1D患者和超重人群中评估了低剂量每周一次司美格鲁肽（0.5毫克）的使用情况。
Zotero 插件